ANKRD17 divergent transcript (ANKRD17-DT)

ANKRD17 divergent transcript (ANKRD17-DT) is classified as a long non-coding RNA (lncRNA) gene that is transcribed in the region adjacent to the ANKRD17 protein-coding gene but does not encode a protein itself[1]. Its specific biological function, disease association, or role as a therapeutic target is not described in curated biomedical sources. Most information shown in databases is limited to its RNA gene status, with little to no functional characterization or clinical relevance currently known[1]. ANKRD17-DT is not a protein, receptor, enzyme, transporter, or classic therapeutic target, but an RNA gene (specifically, a divergent non-coding transcript)[1]. The canonical abbreviation "ANKRD17-DT" and full name "ANKRD17 divergent transcript" both match current usage, and no further common aliases are established[1]. There is no evidence in the literature or databases for any drug targeting, major biological function, or biomarker role for ANKRD17-DT at this time. This target is marked as "is_incorrect: true" for typical therapeutic target purposes due to lack of functionality, mechanism, or even basic definition as a relevant target.

Other names

ANKRD17-DTANKRD17 divergent transcript

Not applicable